HT-29

Human colon cancer cell line

Overview

HT-29 is a human colorectal adenocarcinoma cell line that is widely used in cancer research. It was originally derived from a primary tumor of a 44-year-old Caucasian female. HT-29 cells are known for their ability to differentiate into enterocyte-like cells under certain conditions, making them a valuable model for studying intestinal epithelial cell biology and cancer.

Characteristics

HT-29 cells are epithelial in nature and exhibit a polygonal shape. They grow as a monolayer and have a doubling time of approximately 24 hours under optimal conditions. These cells are adherent and require a surface to attach to for growth. HT-29 cells are known for their high degree of aneuploidy, which is a common feature in cancer cells.

Growth Conditions

HT-29 cells are typically cultured in Dulbecco's Modified Eagle Medium (DMEM) supplemented with 10% fetal bovine serum (FBS) and antibiotics such as penicillin and streptomycin. They are maintained at 37°C in a humidified atmosphere containing 5% carbon dioxide.

Differentiation

Under specific conditions, such as the presence of sodium butyrate, HT-29 cells can differentiate into cells that resemble mature intestinal epithelial cells. This property is utilized in studies investigating intestinal absorption, barrier function, and the effects of various compounds on intestinal health.

Applications in Research

HT-29 cells are extensively used in cancer research to study the mechanisms of colorectal cancer progression and to test potential therapeutic agents. They serve as a model for understanding the biology of intestinal epithelial cells and the processes of differentiation and tumorigenesis.

Drug Testing

Due to their human origin and cancerous nature, HT-29 cells are frequently used in drug screening assays to evaluate the efficacy and toxicity of new anticancer drugs. Researchers can assess the impact of these drugs on cell proliferation, apoptosis, and other cellular processes.

Molecular Studies

HT-29 cells are also employed in molecular biology studies to investigate gene expression, signal transduction pathways, and the role of specific genes in cancer development. Techniques such as CRISPR-Cas9 gene editing and RNA interference are often used to manipulate gene expression in these cells.

Limitations

While HT-29 cells provide a useful model for studying colorectal cancer, they have limitations. As a cell line, they may not fully recapitulate the complexity of human tumors in vivo. Additionally, their genetic and phenotypic characteristics can change over time with continuous passaging, which may affect experimental outcomes.

Related pages

• Colorectal cancer
• Cell culture
• Cancer research
• Adenocarcinoma